Tesla’s “Terafab” semiconductor ambitions to launch this week carry an estimated price tag of $25-40 billion. The math is ...
Alzamend Neuro, Inc. (Nasdaq: ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel ...
The S&P 500 fell into a bear market in 2022, then finally forged a bottom late that year before beginning its long climb back. Meanwhile, the Energy Select Sector SPDR Fund surged ...